JP2001513106A - グルココルチコイドと局所麻酔剤との相乗的な併用による好酸球関連病態、例えば気管支喘息の治療 - Google Patents

グルココルチコイドと局所麻酔剤との相乗的な併用による好酸球関連病態、例えば気管支喘息の治療

Info

Publication number
JP2001513106A
JP2001513106A JP53770098A JP53770098A JP2001513106A JP 2001513106 A JP2001513106 A JP 2001513106A JP 53770098 A JP53770098 A JP 53770098A JP 53770098 A JP53770098 A JP 53770098A JP 2001513106 A JP2001513106 A JP 2001513106A
Authority
JP
Japan
Prior art keywords
local anesthetic
use according
alkyl
eosinophil
glucocorticoid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP53770098A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001513106A5 (enExample
Inventor
ジェイ． グレイク，ジェラルド
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mayo Foundation for Medical Education and Research
Original Assignee
Mayo Clinic in Florida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mayo Clinic in Florida filed Critical Mayo Clinic in Florida
Publication of JP2001513106A publication Critical patent/JP2001513106A/ja
Publication of JP2001513106A5 publication Critical patent/JP2001513106A5/ja
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP53770098A 1997-02-26 1998-02-26 グルココルチコイドと局所麻酔剤との相乗的な併用による好酸球関連病態、例えば気管支喘息の治療 Ceased JP2001513106A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/805,623 1997-02-26
US08/805,623 US5837713A (en) 1997-02-26 1997-02-26 Treatment of eosinophil-associated pathologies by administration of topical anesthetics and glucocorticoids
PCT/US1998/002960 WO1998037896A1 (en) 1997-02-26 1998-02-26 Treatment of eosinophil-associated pathologies, such as bronchial asthma, with synergistic combinations of glucocorticoids and a local anesthetics

Publications (2)

Publication Number Publication Date
JP2001513106A true JP2001513106A (ja) 2001-08-28
JP2001513106A5 JP2001513106A5 (enExample) 2005-10-06

Family

ID=25192051

Family Applications (1)

Application Number Title Priority Date Filing Date
JP53770098A Ceased JP2001513106A (ja) 1997-02-26 1998-02-26 グルココルチコイドと局所麻酔剤との相乗的な併用による好酸球関連病態、例えば気管支喘息の治療

Country Status (6)

Country Link
US (1) US5837713A (enExample)
EP (1) EP0979085A1 (enExample)
JP (1) JP2001513106A (enExample)
AU (1) AU6327498A (enExample)
CA (1) CA2282639A1 (enExample)
WO (1) WO1998037896A1 (enExample)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006126581A1 (ja) * 2005-04-28 2006-11-30 Dainippon Sumitomo Pharma Co., Ltd. 組合せ医薬
JP2007518817A (ja) * 2004-01-21 2007-07-12 シェーリング　コーポレイション 処置方法
JP2008501726A (ja) * 2004-06-07 2008-01-24 ファンダカオ オスワルド クルズ−フィオクルズ リドカインから誘導される化合物、薬学的組成物、使用法、および疾患の治療、予防または抑制の方法
JP4865792B2 (ja) * 2005-07-12 2012-02-01 赴朝 李 局所麻酔薬の効果増強・時間延長剤
JP2012532887A (ja) * 2009-07-10 2012-12-20 プレジデント アンド フェロウズ オブ ハーバード カレッジ 抗炎症剤としての恒久的に荷電したナトリウムおよびカルシウムチャンネルブロッカー
US11021443B2 (en) 2015-08-03 2021-06-01 President And Fellows Of Harvard College Charged ion channel blockers and methods for use

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL125658A0 (en) 1997-08-18 1999-04-11 Hoffmann La Roche Ccr-3 receptor antagonists
US6339087B1 (en) 1997-08-18 2002-01-15 Syntex (U.S.A.) Llc Cyclic amine derivatives-CCR-3 receptor antagonists
WO1999032148A1 (en) * 1997-12-19 1999-07-01 Beth Israel Deaconess Medical Center Methods and compositions for inhibiting tumor cell growth
US6598603B1 (en) * 1997-12-31 2003-07-29 Astra Aktiebolag Method for treating respiratory diseases
AU7847800A (en) 1999-10-15 2001-04-30 Mayo Foundation For Medical Education And Research Topical anesthetics useful for treating cancer, autoimmune diseases and ischemia
US20020046357A1 (en) * 1999-12-28 2002-04-18 Jiandong Huang Software-based fault tolerant networking using a single LAN
USRE44145E1 (en) 2000-07-07 2013-04-09 A.V. Topchiev Institute Of Petrochemical Synthesis Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties
US8840918B2 (en) 2001-05-01 2014-09-23 A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences Hydrogel compositions for tooth whitening
WO2002087642A2 (en) 2001-05-01 2002-11-07 A.V. Topchiev Institute Of Petrochemical Synthesis Two-phase, water-absorbent bioadhesive composition
US8206738B2 (en) 2001-05-01 2012-06-26 Corium International, Inc. Hydrogel compositions with an erodible backing member
US20050215727A1 (en) 2001-05-01 2005-09-29 Corium Water-absorbent adhesive compositions and associated methods of manufacture and use
US20050113510A1 (en) 2001-05-01 2005-05-26 Feldstein Mikhail M. Method of preparing polymeric adhesive compositions utilizing the mechanism of interaction between the polymer components
US8541021B2 (en) 2001-05-01 2013-09-24 A.V. Topchiev Institute Of Petrochemical Synthesis Hydrogel compositions demonstrating phase separation on contact with aqueous media
EP1390085B1 (en) 2001-05-01 2009-08-05 A.V. Topchiev Institute of Petrochemical Synthesis Hydrogel compositions
WO2002089849A1 (en) * 2001-05-07 2002-11-14 Corium International Compositions and delivery systems for administration of a local anesthetic agent
US20070122353A1 (en) 2001-05-24 2007-05-31 Hale Ron L Drug condensation aerosols and kits
US7090830B2 (en) 2001-05-24 2006-08-15 Alexza Pharmaceuticals, Inc. Drug condensation aerosols and kits
WO2002094238A1 (en) * 2001-05-24 2002-11-28 Alexza Molecular Delivery Corporation Delivery of anti-migraine compounds through an inhalation route
US7458374B2 (en) 2002-05-13 2008-12-02 Alexza Pharmaceuticals, Inc. Method and apparatus for vaporizing a compound
US20030051728A1 (en) 2001-06-05 2003-03-20 Lloyd Peter M. Method and device for delivering a physiologically active compound
AU2002310074B2 (en) * 2001-05-24 2008-09-04 Alexza Pharmaceuticals, Inc. Delivery of compounds for the treatment of migraine through an inhalation route
US7585493B2 (en) 2001-05-24 2009-09-08 Alexza Pharmaceuticals, Inc. Thin-film drug delivery article and method of use
CA2446904A1 (en) 2001-05-24 2003-04-03 Alexza Molecular Delivery Corporation Delivery of drug esters through an inhalation route
RU2209092C2 (ru) * 2001-10-03 2003-07-27 Пермская государственная медицинская академия Способ лечения аллергических заболеваний респираторного тракта
RU2236219C2 (ru) * 2002-06-03 2004-09-20 Чепурная Мария Михайловна Способ лечения бронхиальной астмы у детей в приступном периоде
US20040076671A1 (en) * 2002-10-21 2004-04-22 Aletha Tippett Methods and compositions for topical wound treatment
US20040234914A1 (en) 2003-05-21 2004-11-25 Alexza Molecular Delivery Corporation Percussively ignited or electrically ingnited self-contained heating unit and drug-supply unit employing same
WO2005025498A2 (en) * 2003-09-08 2005-03-24 Corus Pharma Substituted acetanilides and benzamides for the treatment of asthma and pulmonary inflammation
WO2005044233A1 (en) * 2003-11-04 2005-05-19 Corus Pharma Formulations of n-oxide prodrugs of local anesthetics for the treatment of pulmonary inflammation associated with asthma, brochitis, and copd
US20070020299A1 (en) 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
RU2390330C2 (ru) 2003-12-31 2010-05-27 Сайдекс, Инк. Ингаляционная препаративная форма, содержащая простой сульфоалкиловый эфир гамма-циклодекстрина и кортикостероид
US7452523B2 (en) * 2004-01-27 2008-11-18 Gilead Sciences, Inc. Targeted delivery of lidocaine and other local anesthetics and a method for treatment of cough and tussive attacks
US7452524B2 (en) 2004-01-27 2008-11-18 Gilead Sciences, Inc. Method for improvement of tolerance for therapeutically effective agents delivered by inhalation
AU2005210637B2 (en) 2004-01-30 2010-09-16 A.V. Topchiev Institute Of Petrochemical Synthesis Rapidly dissolving film for delivery of an active agent
US8003616B2 (en) 2004-04-23 2011-08-23 Albert Rory J Composition for the treatment of ear infections and method
US7540286B2 (en) 2004-06-03 2009-06-02 Alexza Pharmaceuticals, Inc. Multiple dose condensation aerosol devices and methods of forming condensation aerosols
US9242021B2 (en) 2004-08-05 2016-01-26 Corium International, Inc. Adhesive composition
EP1781360A1 (en) 2004-08-12 2007-05-09 Alexza Pharmaceuticals, Inc. Aerosol drug delivery device incorporating percussively activated heat packages
WO2006036181A1 (en) * 2004-09-20 2006-04-06 Corus Pharma, Inc. Inhalable lidocaine formulation for treatment of asthma and for reducing the need for corticosteroids in asthmatic patients
WO2006060027A2 (en) * 2004-09-20 2006-06-08 Corus Pharma, Inc. A method for improvement of tolerance for therapeutically effective agents delivered by inhalation
WO2006065722A2 (en) * 2004-12-16 2006-06-22 Advanced Inhalation Research, Inc. Compositions and methods for pulmonary conditions
US8277780B2 (en) * 2005-05-27 2012-10-02 Taro Pharmaceutical North America, Inc. Stable liquid desoximethasone compositions with reduced oxidized impurity
JP2009514969A (ja) * 2005-11-09 2009-04-09 コンビナトアールエックス インコーポレーティッド 医学的状態を治療するための方法、組成物、およびキット
US8679545B2 (en) 2005-11-12 2014-03-25 The Regents Of The University Of California Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US8324192B2 (en) * 2005-11-12 2012-12-04 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US20070197486A1 (en) * 2005-12-20 2007-08-23 Verus Pharmaceuticals, Inc. Methods and systems for the delivery of corticosteroids
US20070178049A1 (en) * 2005-12-20 2007-08-02 Verus Pharmaceuticals, Inc. Systems and methods for the delivery of corticosteroids having an enhanced pharmacokinetic profile
US20070249572A1 (en) * 2005-12-20 2007-10-25 Verus Pharmaceuticals, Inc. Systems and methods for the delivery of corticosteroids
US20070160542A1 (en) * 2005-12-20 2007-07-12 Verus Pharmaceuticals, Inc. Methods and systems for the delivery of corticosteroids having an enhanced pharmacokinetic profile
US20070185066A1 (en) * 2005-12-20 2007-08-09 Verus Pharmaceuticals, Inc. Systems and methods for the delivery of corticosteroids
WO2007095342A2 (en) * 2006-02-15 2007-08-23 Tika Läkemedel Ab Stable corticosteroid mixtures
KR20140097446A (ko) 2006-11-20 2014-08-06 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 통증 및 소양증 치료용 방법, 조성물 및 키트
EP2121088B1 (en) 2007-03-09 2016-07-13 Alexza Pharmaceuticals, Inc. Heating unit for use in a drug delivery device
US12370352B2 (en) 2007-06-28 2025-07-29 Cydex Pharmaceuticals, Inc. Nasal and ophthalmic delivery of aqueous corticosteroid solutions
CA2705681C (en) 2007-11-13 2013-06-18 Meritage Pharma, Inc. Corticosteroid compositions
US20090123551A1 (en) * 2007-11-13 2009-05-14 Meritage Pharma, Inc. Gastrointestinal delivery systems
US20100216754A1 (en) * 2007-11-13 2010-08-26 Meritage Pharma, Inc. Compositions for the treatment of inflammation of the gastrointestinal tract
US20090123390A1 (en) * 2007-11-13 2009-05-14 Meritage Pharma, Inc. Compositions for the treatment of gastrointestinal inflammation
US20090264392A1 (en) * 2008-04-21 2009-10-22 Meritage Pharma, Inc. Treating eosinophilic esophagitis
CA2751884C (en) 2009-01-14 2018-09-25 Corium International, Inc. Transdermal administration of tamsulosin
US9867834B2 (en) 2015-06-15 2018-01-16 Banner Life Sciences Llc Non-systemic topical compositions comprising corticosteroids
WO2016205172A1 (en) 2015-06-15 2016-12-22 Banner Life Sciences Llc Soft lozenges comprising corticosteroids
MX2020007997A (es) 2018-02-02 2020-12-03 Alexza Pharmaceuticals Inc Dispositivo electrico de aerosol de condensacion.
BR112021017772A2 (pt) 2019-03-11 2021-11-16 Nocion Therapeutics Inc Bloqueadores de canais de íons carregados e métodos para uso
US10780083B1 (en) 2019-03-11 2020-09-22 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
EP3937945A4 (en) 2019-03-11 2023-01-04 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
MX2021010869A (es) 2019-03-11 2022-01-19 Nocion Therapeutics Inc Bloqueadores de canales iónicos sustituidos por éster y métodos para su uso.
US10786485B1 (en) 2019-03-11 2020-09-29 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
WO2021091586A1 (en) 2019-11-06 2021-05-14 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
WO2021091585A1 (en) 2019-11-06 2021-05-14 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US12162851B2 (en) 2020-03-11 2024-12-10 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
EP4118070A4 (en) 2020-03-11 2024-04-10 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4626530A (en) * 1981-06-23 1986-12-02 Schulte Thomas L Treatment of eye inflammation with biphenamine
RO82578A2 (ro) * 1981-08-01 1983-09-26 Intreprinderea De Antibiotice,Ro Gel pentru intubatie traheala
US4466973A (en) * 1983-02-01 1984-08-21 Thomas Rennie Method of treating nasal and sinus congestion
US4748022A (en) * 1985-03-25 1988-05-31 Busciglio John A Topical composition
US4866050A (en) * 1988-04-27 1989-09-12 Ben Amoz Daniel Ultrasonic transdermal application of steroid compositions
US5134166A (en) * 1988-12-02 1992-07-28 Genderm Corporation Method for treating nasal disorders and headaches
US5008289A (en) * 1988-12-02 1991-04-16 Galenpharma, Inc. Composition for treating nasal disorders and headaches
US5700485A (en) * 1992-09-10 1997-12-23 Children's Medical Center Corporation Prolonged nerve blockade by the combination of local anesthetic and glucocorticoid
US5510339A (en) * 1993-02-02 1996-04-23 Mayo Foundation For Medical Education And Research Method for the treatment of bronchial asthma by administration of topical anesthetics

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007518817A (ja) * 2004-01-21 2007-07-12 シェーリング　コーポレイション 処置方法
JP2008110991A (ja) * 2004-01-21 2008-05-15 Schering Corp 処置方法
JP2008501726A (ja) * 2004-06-07 2008-01-24 ファンダカオ オスワルド クルズ−フィオクルズ リドカインから誘導される化合物、薬学的組成物、使用法、および疾患の治療、予防または抑制の方法
WO2006126581A1 (ja) * 2005-04-28 2006-11-30 Dainippon Sumitomo Pharma Co., Ltd. 組合せ医薬
JP4865792B2 (ja) * 2005-07-12 2012-02-01 赴朝 李 局所麻酔薬の効果増強・時間延長剤
JP2012532887A (ja) * 2009-07-10 2012-12-20 プレジデント アンド フェロウズ オブ ハーバード カレッジ 抗炎症剤としての恒久的に荷電したナトリウムおよびカルシウムチャンネルブロッカー
JP2017178948A (ja) * 2009-07-10 2017-10-05 プレジデント アンド フェローズ オブ ハーバード カレッジ 抗炎症剤としての恒久的に荷電したナトリウムおよびカルシウムチャンネルブロッカー
US10729664B2 (en) 2009-07-10 2020-08-04 President And Fellows Of Harvard College Permanently charged sodium and calcium channel blockers as anti-inflammatory agents
US11021443B2 (en) 2015-08-03 2021-06-01 President And Fellows Of Harvard College Charged ion channel blockers and methods for use

Also Published As

Publication number Publication date
EP0979085A1 (en) 2000-02-16
AU6327498A (en) 1998-09-18
US5837713A (en) 1998-11-17
CA2282639A1 (en) 1998-09-03
WO1998037896A1 (en) 1998-09-03

Similar Documents

Publication Publication Date Title
JP2001513106A (ja) グルココルチコイドと局所麻酔剤との相乗的な併用による好酸球関連病態、例えば気管支喘息の治療
AU685777B2 (en) Use of topical anesthetics for the manufacture of a medicament for the treatment of bronchial asthma
US11975005B2 (en) Treatment of respiratory diseases
WO1994017790A9 (en) Use of topical anesthetics for the manufacture of a medicament for the treatment of bronchial asthma
KR100234864B1 (ko) 기도 및 폐질환을 치료하기 위한 모메타손푸로에이트 약제
RU2327450C2 (ru) Фармацевтические продукты и композиции, содержащие специфические антихолинергические средства, агонисты бета-2 и кортикостероиды
CH680983A5 (enExample)
FR2651678A1 (fr) Composition pharmaceutique a base de salmeterol et de dipropionate de beclometasone.
US20030026766A1 (en) Medicaments for treating respiratory disorders comprising formoterol and fluticasone
US20040009963A1 (en) Use of salmeterol and fluticasone propionate combination
AU1321401A (en) New combination comprising a beta 2 (beta)2 adreno receptor agonist and a leukotriene receptor antagonist
CN1306429A (zh) 糖皮质类固醇在制备治疗轻度/早期c opd(慢性阻塞性肺病)的药物中的应用
Remington et al. Combined budesonide/formoterol turbuhaler treatment of asthma
AU4584702A (en) Treatment of eosinophil-associated pathologies such as bronchial asthma with synergistic combinations of glucocorticoids and a local anesthetics
JP5220741B2 (ja) アンドラスト／グルココルチコイドの併用
WO2022242768A1 (zh) 一种吡咯并嘧啶类化合物的应用
CN118806743A (zh) 高瓜氨酸在治疗炎症性疾病和/或呼吸系统疾病中的应用
CN110664819A (zh) 供吸入的齐墩果酸制剂及其制备方法与医药用途
PEDROSO et al. Effect of nebulized corticosteroids on lung function in patients with chronic asthma
ZA200208804B (en) Medicaments for treating respiratory disorders comprising formoterol and fluticasone.

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050228

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050228

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20080916

A313 Final decision of rejection without a dissenting response from the applicant

Free format text: JAPANESE INTERMEDIATE CODE: A313

Effective date: 20090127

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20090407